Senate drug pricing hearing
Executive Summary
Witnesses during July 18 Senate Health Committee hearing on "Prescription Drug Costs: What Drives Increases?" will include Pharmaceutical Research & Manufactures of America Exec VP Judith Bello, Rx Health Value Executive Director John Golenski, CVS Pharmacy Legislative and Government Affairs Director Carlos Ortiz and Ford Healthcare Management Director Woodrow Myers, MD